Sheetal Desai, MD, leads the discussion on the recent approval of guselkumab, an IL-23 inhibitor, for the treatment of adults with active psoriatic arthritis.
Back
Evaluation and Management of Real-World Cases of Psoriatic Arthritis
Anthony M. Turkiewicz, MD; Leonard H. Calabrese, DO; Sheetal Desai, MD; and Ana-Maria Orbai, MD, MHS, share insight on currently available biologic therapies, diagnostic strategies, and real-world case scenarios of psoriatic arthritis.
Evaluation and Management of Real-World Cases of Psoriatic Arthritis
Episodes
All
All
Advertisement
Advertisement
Trending on HCPLive
1
Alpha-Gal Syndrome: Closing an Underrecognized Allergy Diagnostic Gap
2
GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF
3
ORFAN-MAESTRIA: AI Predicts Cardioembolic Stroke, Atrial Fibrillation from CT Scans
4
Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial
5